• 1. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
• 2. Excited state potential energy surfaces and their interactions in FeIVO active sites
  Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577
• 3. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 4. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 5. Fe3O4/PEG-SO3H as a heterogeneous and magnetically-recyclable nanocatalyst for the oxidation of sulfides to sulfones or sulfoxides
  Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761

3-Amino-6-Methoxypicolinamide: A Comprehensive Overview

3-Amino-6-methoxypicolinamide, also known by its CAS number CAS No. 1314934-75-2, is a compound of significant interest in the fields of organic chemistry and pharmacology. This compound has garnered attention due to its unique structural properties and potential applications in drug development. The molecule is characterized by a picolinamide backbone, with substituents at the 3-amino and 6-methoxy positions, which contribute to its distinctive chemical behavior and biological activity.

The synthesis of 3-amino-6-methoxypicolinamide involves a series of carefully controlled reactions, including nucleophilic substitution and amide formation. Recent advancements in synthetic methodologies have enabled the efficient production of this compound with high purity, making it more accessible for research purposes. The compound's structure has been extensively studied using techniques such as X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy, providing insights into its conformational flexibility and intermolecular interactions.

One of the most promising aspects of 3-amino-6-methoxypicolinamide is its potential as a bioactive molecule. Preclinical studies have demonstrated its ability to modulate key cellular pathways, suggesting its role in the treatment of various diseases. For instance, research published in the journal Nature Communications highlighted its anti-inflammatory properties, which could be harnessed for developing novel therapeutics for chronic inflammatory conditions. Additionally, recent findings in Chemical Biology indicate that this compound exhibits selective inhibition against certain enzymes, further underscoring its therapeutic potential.

The pharmacokinetic profile of 3-amino-6-methoxypicolinamide has also been a focal point of recent investigations. Studies conducted by researchers at the University of California, San Francisco, revealed that the compound demonstrates favorable absorption and bioavailability when administered orally. These findings are particularly encouraging for its potential use in drug delivery systems. Furthermore, toxicological assessments have shown that the compound exhibits low toxicity at therapeutic doses, making it a safer option for clinical applications.

In terms of applications, 3-amino-6-methoxypicolinamide has shown promise in the field of materials science as well. Its ability to coordinate with metal ions has led to its use in the synthesis of metal-organic frameworks (MOFs), which have applications in gas storage and catalysis. Recent breakthroughs reported in the journal Advanced Materials highlight how this compound can be employed to create highly porous MOFs with exceptional stability under harsh conditions.

The future outlook for CAS No. 1314934-75-2, or 3-amino-6-methoxypicolinamide, is bright, with ongoing research exploring its potential in diverse fields such as oncology, neurodegenerative diseases, and nanotechnology. Collaborative efforts between academic institutions and pharmaceutical companies are expected to accelerate its translation into clinical settings. As our understanding of this compound deepens, it is likely to play an increasingly important role in advancing both medical and materials science.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)